Listeria monocytogenes is an environmental gram-positive, motile bacillus which has the ability to survive and multiply in phagocytic host cells. The main route of infection acquisition is through the intestinal tract after ingestion of contaminated food products, as well ulation is particularly scarce. Significantly, risk factors for listeriosis in SOT recipients have not been formally assessed. We conducted the present multicenter study to identify the risk factors for sporadic listeriosis in SOT recipients with a 1:2 matched case-control study design and to review the clinical features, microbiological characteristics, and outcomes for all case patients.
MATERIALS AND METHODS
Setting and study population. The study was conducted in 15 Spanish tertiary care hospitals with active organ transplantation programs, including liver, kidney, heart, lung, pancreas, intestinal, and multivisceral transplantation. All patients with culture-proven listeriosis from January 1995 through December 2007 were included in the analysis. Patients were identified from the hospital microbiology and transplantation program databases; initial identification was followed by a detailed review of patient medical records. The study was approved by the institutional review boards of the participating transplantation centers.
For the purposes of risk factor analysis, a matched casecontrol study (1:2 ratio) was performed. Two control subjects were included for each case patient with listeriosis. The control subjects were matched for 3 characteristics: (1) institution, (2) type of transplantation, and (3) time of transplantation. The recipients who underwent transplants immediately before and after the index case patient and who survived at least as long as the time to diagnosis of listeriosis were categorized as control subjects.
Clinical data and definitions. For the case patients, the "time of event" was defined as the time of Listeria infection diagnosis; for the control subjects, the time of Listeria infection in the corresponding case patient was used. Variables analyzed for both case patients and control subjects included patient demographic data, transplant type, prior transplantation, presence of diabetes mellitus, immunosuppressive drugs at the time of the event, an elevated mean calcineurin inhibitor level within the preceding 30 days (115 mg/mL for tacrolimus and 1300 ng/ mL for cyclosporin), history of high-dose prednisone therapy within the preceding 6 months (у20 mg of prednisone for у1 month or 12 pulses of 1 g of intravenous methylprednisolone), receipt of a lymphocyte-depleting antibody within the preceding 12 months, trimethoprim-sulfamethoxazole (TMP-SMX) prophylaxis at the time of the event, allograft rejection within the preceding 6 months, history of cytomegalovirus (CMV) infection or disease within the preceding 6 months, mean lymphocyte and neutrophil counts within 30 days of the event, and mortality rates at 30 days and 1 year after the event.
For all case patients, clinical characteristics and laboratory data at the time of Listeria infection, treatment, and outcomes were exhaustively evaluated. Hypoalbuminemia at the time of Listeria infection was considered to be present when the serum albumin level was !3 g/L. Renal impairment was defined as a serum creatinine level 11.5 mg/dL. Meningoencephalitis was considered to be present in case of culture-proven Listeria infection and suggestive neurological symptoms not attributable to any other etiology, even if cerebrospinal fluid (CSF) cultures had negative results or were not performed. CMV infection was diagnosed by growing the virus in vitro, finding evidence of viral infection by intracytoplasmic or intranuclear inclusions or by antibody-based staining techniques for CMV in histopathologic sections or by finding evidence of replication using nucleic acid-based assays or antigenemia studies. CMV disease was defined as evidence of CMV infection with attributable symptoms, as described elsewhere [10] .
Microbiological studies. Each hospital's microbiology laboratory identified organisms as L. monocytogenes and performed susceptibility testing. L. monocytogenes strains were identified according to their colony characteristics, Gram stain morphology, motility, catalase activity and conventional microbiological procedures [11] . Serotyping was performed using specific antisera (Difco; Becton Dickinson). Susceptibility testing was performed with the microdilution method according to the guidelines of the Clinical Laboratory Standards Institute 2006 [12] . The strains with minimal inhibitory concentration (MIC) of ampicillin р2 mg/L and MIC of TMP-SMZ (р0.5 and р9.5 mg/L), were considered to be susceptible according to Clinical Laboratory Standards Institute criteria.
Statistical analysis. To detect statistically significant differences between specified groups, we used the x 2 test with continuity correction for categorical variables and the Student's t test for continuous variables. Univariate odds ratios (OR) were calculated for the potential risk factors for Listeria infection. Multivariable conditional logistic-regression analysis of factors potentially associated with Listeria infection included all statistically significant variables in univariate analysis and all clinically important variables, whether they were statistically significant or not [13] . The analysis was performed with the stepwise logistic-regression model of the SPSS software package (SPSS). The Mantel-Haenszel test was used to analyze trends in the frequency of listeriosis over time. In all analyses, we considered P values !.05 to be statistically significant. All reported P values are 2-tailed.
RESULTS
Epidemiology. Thirty L. monocytogenes infections were identified among 25,997 transplant recipients; infections were identified at 10 of the 15 participating hospitals. This figure represented 0.12% of all transplant recipients and included 14 (0.18%) of 7901 liver recipients, 8 (0.06%) of 12,390 kidney recipients, 4 (0.12%) of 3260 heart recipients, 2 (0.12%) of 1729 lung recipients, and 2 (0.29%) of 677 multivisceral re- Table 1 . On univariate analysis, diabetes mellitus, CMV infection or disease within the preceding 6 months, receipt of high-dose prednisone within the preceding 6 months, and the presence of allograft rejection within the preceding 6 months were significantly associated with listeriosis. There were 5 case patients with asymptomatic CMV infection and 3 case patients with CMV disease.
After applying a conditional logistic regression model (Table  2) , diabetes mellitus (OR, 5.6; 95% CI, 1.6-19.6; ), P p .007 history of CMV infection or disease within the preceding 6 months (OR, 35.9; 95% CI, 2.1-620;
), and receipt of P p .014 high-dose prednisone within the preceding 6 months (OR, 6.2; 95% CI, 1.8-21.1;
) were found to be independent P p .003 risk factors for Listeria infection in SOT recipients, whereas TMP-SMZ prophylaxis at the time of event was found to be a protective factor (OR, 0.07; 95% CI, 0.006-0.76;
). P p .029 Clinical characteristics of Listeria infection in SOT recipients. The clinical characteristics of the 30 SOT recipients with listeriosis are shown in Table 3 . Seventeen patients (56.7%) were men, with a median age of 58.6 years. The median duration of symptoms prior to hospitalization was 3 days. Twentysix patients (86.7%) had bacteremia, and 7 of these patients had septic shock at presentation. Other manifestations included meningoencephalitis, spontaneous peritonitis, pleural empyema, brain abscesses, and liver abscesses. As detailed in Table 3 a High-dose prednisone was defined as у20 mg of prednisone for у1 month or 12 pulses of 1 g intravenous methylprednisolone.
Variables included in the analysis were sex, age, diabetes mellitus, CMV disease or infection within the preceding 6 months, receipt of high-dose prednisone within the preceding 6 months, allograft rejection within the preceding 6 months, and receipt of TMP-SMZ prophylaxis at the time of the event.
culture ( ), and surgical specimen culture of brain abscess n p 1 pus (
). Serotypes and antimicrobial susceptibility were n p 1 investigated in 13 L. monocytogenes isolates. The most frequent serotypes were 4 ( ) and 1 ( ). All strains were susn p 9 n p 4 ceptible to ampicillin and TMP-SMZ.
Treatment and outcomes. As shown in Table 3 , 28 patients (93.3%) were treated with ampicillin, and 11 of them were also given gentamicin. The initial intravenous treatment with ampicillin was switched to oral TMP-SMZ in 11 cases. Two liver transplant recipients presented with multiple brain and liver abscesses that required surgical and percutaneous drainage respectively. One heart transplant recipient had an acute episode of allograft rejection during treatment of listeriosis. Nine patients (30%) required intensive care unit admission, and 7 of them underwent mechanical ventilation. The median duration of antibiotic therapy was 21 days. Excluding patients who died, the median length of hospital stay was 30 days.
The 30-day mortality rate was 26.7% (8 of 30 patients died). The median time from diagnosis of listeriosis to death was 15 days (range, 6-29 days). Causes of death were sepsis ( ), n p 4 multiorgan failure ( ), respiratory failure ( ), and n p 2 n p 1 neurological complications ( ). The 30-day mortality rate n p 1 was statistically significantly higher among the 10 patients with meningoencephalitis than it was among the 20 case patients who presented with other manifestations (60% vs 10%; OR, 13.5; 95% CI, 
DISCUSSION
In recent years, the incidence of laboratory-confirmed invasive listeriosis in the general population in developed countries has decreased [14] . Surveillance programs have documented rates of infection ranging from 0.6 through 6.2 cases per million individuals [15] . The reported incidence of listeriosis among recipients of allogeneic blood and marrow transplants is much higher, ranging from 0.39% through 0.47% [16, 17] . To our knowledge, the frequency of listeriosis among recipients of a broad range of organ transplant types has not been evaluated. In the present multicenter study, the prevalence of sporadic listeriosis among SOT recipients was 0.12%. The prevalence was highest among the group of multivisceral recipients (0.29%), followed by liver transplant recipients (0.18%). This latter figure is similar to that encountered in a study reporting 1 case of listeriosis among 539 liver recipients (0.19%) at a single institution [5] .
In our study, independent risk factors for Listeria infection in SOT recipients were diabetes mellitus, history of CMV infection or disease within the preceding 6 months, and receipt of high-dose prednisone within the preceding 6 months, whereas TMP-SMZ prophylaxis was a protective factor.
Several aspects of immunity, such as polymorphonuclear leukocyte function (ie, leukocyte adherence, chemotaxis, and phagocytosis) and bactericidal activity of serum are depressed in patients with diabetes mellitus [18, 19] . Consequently, certain specific infections are particularly common among these patients. Previous observational studies have suggested that diabetes mellitus may be a predisposing factor for developing listeriosis [3, 20] . Interestingly, experimental studies have also linked hyperglycemia to a greater susceptibility to L. monocytogenes infection [21] . In our study, 50% of recipients with listeriosis had diabetes mellitus, compared with 15% of control subjects. In recent years, posttransplant diabetes mellitus has emerged as a major adverse event associated with the receipt of immunosuppressive drugs [22, 23] . Therefore, developing strategies aimed to minimize this effect should be a focus of future research.
CMV infection may cause both invasive disease (ie, "direct effects") and a variety of secondary immune phenomena in transplant recipients [24] [25] [26] . The immunomodulatory effects of CMV are increasingly recognized, with previous reports associating CMV infection with other viral, bacterial, fungal, and CMV infection or disease 7
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Enterococcus faecalis 1 protozoan infections [27] . Interestingly, CMV disease has been associated with listeriosis in previous studies of blood and bone marrow transplantation [16] . Nevertheless, its role as an independent risk factor for listeriosis in SOT recipients has not been previously identified. Our data provide additional support for aggressive management of CMV disease to prevent the "indirect" effects of CMV infection. Prednisone is a broad-acting immunosuppressant, affecting both the innate and adaptive immune responses. The use of steroids exerts a decisive influence on the immune function of macrophages and granulocytes, which are the main cell host defenses against bacteria. In our study, receipt of high-dose prednisone within the preceding 6 months was identified as an independent risk factor for listeriosis. The association of steroid use and Listeria infection has been well established in previous studies [6, 7, 28] .
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At present, SOT recipients are given TMP-SMZ for the first 6 months after transplantation for Pneumocystis jirovecii pneumonia prophylaxis in many centers. The routine use of TMP-SMZ has effectively eliminated this infectious complication [2, 29] . Nevertheless, in a recent study [30] , TMP-SMZ prophylaxis was not shown to be protective against Nocardia infection. Given the excellent activity of TMP-SMZ against L. monocytogenes [31] , some investigators have argued that its administration might help to prevent listeriosis. In fact, it has been hypothesized that the low prevalence of this infection among SOT recipients may be attributable to the use of TMP-SMZ [28, 32, 33] . However, no study has formally tested this assumption. Significantly, we found that TMP-SMZ prophylaxis is a protective factor for listeriosis. According to our data, 50% of cases of listeriosis in SOT recipients occur 16 months after transplantation. Therefore, extended prophylaxis should be carefully considered for patients at high risk of listeriosis (eg, those with diabetes mellitus, those who receive high-dose prednisone, and those who develop CMV infection or disease). Moreover, it should be borne in mind that nearly all cases of listeriosis are thought to be food-borne [34] . Therefore, all transplant recipients should be advised to avoid potentially contaminated foods, such as soft cheeses and unheated delicatessen meals. They should also be instructed regarding how to reduce the risk of infection by thorough cooking, avoidance of cross-contamination, and short-term refrigerated storage of perishable foods [35] .
In this study, most of the SOT recipients with L. monocytogenes infection had bacteremia. Meningoencephalitis was also particularly common. Other less common manifestations were peritonitis, pleural empyema, liver abscesses, and brain abscesses. Other investigators have previously reported similar clinical manifestations of L. monocytogenes infection in transplant recipients [4, 7, 8, 9, 28] .
One recent study found that listeriosis-related deaths among the general population decreased over the 16-year study period (1990) (1991) (1992) (1993) (1994) (1995) (1996) (1997) (1998) (1999) (2000) (2001) (2002) (2003) (2004) (2005) [36] . In our study involving SOT recipients, both the 30-day and 1-year mortality rates were high (26.7% and 33.3%, respectively). The mortality was significantly higher among patients presenting with meningoencephalitis, reaching 60%. This finding corroborates those of previous reports [37] [38] [39] [40] . Mizuno et al [37] described 1 case of listeriosis after liver transplantation and reviewed 14 previously reported cases. They found 4 cases of meningitis, with a mortality rate of 50%. Similarly, in a review of cases of listeriosis among renal transplant recipients, Stamm et al [38] found that the mortality rate was higher among patients with meningoencephalitis (37%) than it was among patients presenting with other manifestations (11%).
In conclusion, L. monocytogenes infection is uncommon among SOT recipients but causes high rates of morbidity and mortality, particularly among patients with meningoencephalitis. Independent risk factors for listeriosis are diabetes mellitus, CMV infection or disease, and receipt of high-dose steroids, whereas TMP-SMZ prophylaxis is a protective factor.
